期刊文献+

尼莫地平PLGA微球的制备方法改良及其特性研究 被引量:5

Modified Preparation Method and Characteristics of Nimodipine-Loaded PLGA Microspheres
原文传递
导出
摘要 用乳化-溶剂挥发法制备尼莫地平(nimodipine,NMP)PLGA微球,在油相中引入石油醚与二氯甲烷作混合溶剂,考察了石油醚对微球性质的影响。石油醚与二氯甲烷的不同体积比(0,1∶10,1∶8,1∶4和1∶2)可调节微球的固化速率,从而得到不同特性的载药微球。混合比为1∶10时,微球突释效应减轻,包封率显著提高。以PLGA浓度、投药比及混合溶剂比为考察因素进行了正交优化设计。结果表明优化后微球包封率提高52.2%,突释率降低58.8%,药物以无定形态存在于微球中,与单一溶剂组相比,微球形态有较大改善,微球缓释效应显著增强。 The effect of petroleum ether,as an organic phase co-solvent,on the characteristics of nimodipine(NMP)-loaded poly(lactide-co-glycolide)(PLGA) microspheres prepared via the emulsion-solvent evaporation/extraction process was studied.Different ratio of petroleum ether to dichloromethane(DCM)(0,1∶10,1∶8,1∶4,and 1∶2,v/v) caused different solidification rate,leading to different properties of microspheres.At the ratio of 1∶10,the initial burst of microspheres was attenuated,and the encapsulation efficiency was improved significantly.To perform the orthogonal design for process optimization,polymer concentration,drug/PLGA ratio and ratio of petroleum ether/DCM were set as the factors for investigation.After optimization,the encapsulation efficiency of microspheres was improved by 52.2%,and the initial burst was declined by 58.8%.Drug was encapsulated in the matrix as amorphous state.Compared with microspheres prepared by single solvent,the morphology of the optimal formulation was modified evidently,therefore NMP was released in a more controlled fashion.
出处 《化学工业与工程》 CAS 2013年第1期1-7,共7页 Chemical Industry and Engineering
基金 国家自然科学基金(20836005 21176173)
关键词 微球 潜溶剂 石油醚 形态 体外释放 microspheres co-solvent petroleum ether morphology in vitro release
  • 相关文献

参考文献18

  • 1肖莉,张韵慧,崔颖,晋兴华,李培凡.尼莫地平聚乳酸缓释微球的制备及其药剂学性质[J].中国医院药学杂志,2008,28(3):194-198. 被引量:10
  • 2Xiong R, Lu W, Li ] fet al. Preparation and characteriza-tion of intravenously injectable nimodipine nanosuspen-sion [J ]. International Journal of Pharmaceutics,2008 ,350(1/2) :338 -343.
  • 3Vinge E, Andersson K E,Brandt Lfet al. Pharmacokinet-ics of nimodipine in patients with aneurysmal subarach-noid haemorrhage [ J ]. European Journal of ClinicalPharmacology, 1986,30(4) :421 -425.
  • 4张爱华,姚康德.淫羊藿苷壳聚糖/明胶微球的制备及其体外释放研究[J].高分子通报,2006(4):60-64. 被引量:9
  • 5Li M , Rouaud 0, Poncelet D. Microencapsulation by sol-vent evaporation : State of the art for process engineeringapproaches[ J]. International Journal of Pharmaceutics,2008,363(1/2) :26 -39.
  • 6Jyothi N V N , Prasanna P M,Sakarkar S N,ei al. Micro-encapsulation techniques,factors influencing encapsula-tion efficiency [ J ]. Journal of Microencapsulation, 2010,27(3) :187 -197.
  • 7Rawat A,Burgess D J. Effect of ethanol as a processingco-solvent on the PLGA microsphere characteristics [ J ].International Journal of Pharmaceutics, 2010, 394 ( 1/2) :99-105.
  • 8Yeo Y , Park K. Control of encapsulation efficiency andinitial burst in polymeric microparticle systems [ J ]. Ar-chives of Pharmacal Research ,2004,27 ( 1) :1 - 12.
  • 9Hao H,Liu R, Lan T, ei al. Preparation and in vitro re-lease behavior of urapidil hydrochloride loading into mi-crospheres based on poly( L-lactide) [ J]. Journal of Ap-plied Polymer Science,2010,115(4) :2 317 -2 321.
  • 10Ai-Maaieh A,Flanagan D R. New drug salt formation inbiodegradable microspheres [ J ]. International Journal ofPharmaceutics, 2005 ,303 (1 /2) :153 - 159.

二级参考文献12

共引文献17

同被引文献105

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部